The New York Stock Exchange has officially approved the listing and registration of three new securities for Johnson & Johnson. The securities include 3.200% Notes due in 2032, 3.550% Notes due in 2044, and 3.350% Notes due in 2036. This approval, certified under the Exchange Act of 1934, marks a significant event for Johnson & Johnson, allowing the company to expand its investment offerings to potential investors. The announcement was made on May 21, 2024, and is expected to have an impact on the company's financial flexibility and future growth prospects.

The New York Stock Exchange has officially approved the listing and registration of three new securities for Johnson & Johnson. The securities include 3.200% Notes due in 2032, 3.550% Notes due in 2044, and 3.350% Notes due in 2036. This approval, certified under the Exchange Act of 1934, marks a significant event for Johnson & Johnson, allowing the company to expand its investment offerings to potential investors. The announcement was made on May 21, 2024, and is expected to have an impact on the company's financial flexibility and future growth prospects.